Cargando…

Proteomic analysis reveals dual requirement for Grb2 and PLCγ1 interactions for BCR-FGFR1-Driven 8p11 cell proliferation

Translocation of Fibroblast Growth Factor Receptors (FGFRs) often leads to aberrant cell proliferation and cancer. The BCR-FGFR1 fusion protein, created by chromosomal translocation t(8;22)(p11;q11), contains Breakpoint Cluster Region (BCR) joined to Fibroblast Growth Factor Receptor 1 (FGFR1). BCR-...

Descripción completa

Detalles Bibliográficos
Autores principales: Peiris, Malalage N., Meyer, April N., Warda, Dalida, Campos, Alexandre Rosa, Donoghue, Daniel J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9093983/
https://www.ncbi.nlm.nih.gov/pubmed/35574218
http://dx.doi.org/10.18632/oncotarget.28228
_version_ 1784705447765213184
author Peiris, Malalage N.
Meyer, April N.
Warda, Dalida
Campos, Alexandre Rosa
Donoghue, Daniel J.
author_facet Peiris, Malalage N.
Meyer, April N.
Warda, Dalida
Campos, Alexandre Rosa
Donoghue, Daniel J.
author_sort Peiris, Malalage N.
collection PubMed
description Translocation of Fibroblast Growth Factor Receptors (FGFRs) often leads to aberrant cell proliferation and cancer. The BCR-FGFR1 fusion protein, created by chromosomal translocation t(8;22)(p11;q11), contains Breakpoint Cluster Region (BCR) joined to Fibroblast Growth Factor Receptor 1 (FGFR1). BCR-FGFR1 represents a significant driver of 8p11 myeloproliferative syndrome, or stem cell leukemia/lymphoma, which progresses to acute myeloid leukemia or T-cell lymphoblastic leukemia/lymphoma. Mutations were introduced at Y177F, the binding site for adapter protein Grb2 within BCR; and at Y766F, the binding site for the membrane associated enzyme PLCγ1 within FGFR1. We examined anchorage-independent cell growth, overall cell proliferation using hematopoietic cells, and activation of downstream signaling pathways. BCR-FGFR1-induced changes in protein phosphorylation, binding partners, and signaling pathways were dissected using quantitative proteomics to interrogate the protein interactome, the phosphoproteome, and the interactome of BCR-FGFR1. The effects on BCR-FGFR1-stimulated cell proliferation were examined using the PLCγ1 inhibitor U73122, and the irreversible FGFR inhibitor futibatinib (TAS-120), both of which demonstrated efficacy. An absolute requirement is demonstrated for the dual binding partners Grb2 and PLCγ1 in BCR-FGFR1-driven cell proliferation, and new proteins such as ECSIT, USP15, GPR89, GAB1, and PTPN11 are identified as key effectors for hematopoietic transformation by BCR-FGFR1.
format Online
Article
Text
id pubmed-9093983
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-90939832022-05-13 Proteomic analysis reveals dual requirement for Grb2 and PLCγ1 interactions for BCR-FGFR1-Driven 8p11 cell proliferation Peiris, Malalage N. Meyer, April N. Warda, Dalida Campos, Alexandre Rosa Donoghue, Daniel J. Oncotarget Research Paper Translocation of Fibroblast Growth Factor Receptors (FGFRs) often leads to aberrant cell proliferation and cancer. The BCR-FGFR1 fusion protein, created by chromosomal translocation t(8;22)(p11;q11), contains Breakpoint Cluster Region (BCR) joined to Fibroblast Growth Factor Receptor 1 (FGFR1). BCR-FGFR1 represents a significant driver of 8p11 myeloproliferative syndrome, or stem cell leukemia/lymphoma, which progresses to acute myeloid leukemia or T-cell lymphoblastic leukemia/lymphoma. Mutations were introduced at Y177F, the binding site for adapter protein Grb2 within BCR; and at Y766F, the binding site for the membrane associated enzyme PLCγ1 within FGFR1. We examined anchorage-independent cell growth, overall cell proliferation using hematopoietic cells, and activation of downstream signaling pathways. BCR-FGFR1-induced changes in protein phosphorylation, binding partners, and signaling pathways were dissected using quantitative proteomics to interrogate the protein interactome, the phosphoproteome, and the interactome of BCR-FGFR1. The effects on BCR-FGFR1-stimulated cell proliferation were examined using the PLCγ1 inhibitor U73122, and the irreversible FGFR inhibitor futibatinib (TAS-120), both of which demonstrated efficacy. An absolute requirement is demonstrated for the dual binding partners Grb2 and PLCγ1 in BCR-FGFR1-driven cell proliferation, and new proteins such as ECSIT, USP15, GPR89, GAB1, and PTPN11 are identified as key effectors for hematopoietic transformation by BCR-FGFR1. Impact Journals LLC 2022-05-11 /pmc/articles/PMC9093983/ /pubmed/35574218 http://dx.doi.org/10.18632/oncotarget.28228 Text en Copyright: © 2022 Peiris et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/3.0/) (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Paper
Peiris, Malalage N.
Meyer, April N.
Warda, Dalida
Campos, Alexandre Rosa
Donoghue, Daniel J.
Proteomic analysis reveals dual requirement for Grb2 and PLCγ1 interactions for BCR-FGFR1-Driven 8p11 cell proliferation
title Proteomic analysis reveals dual requirement for Grb2 and PLCγ1 interactions for BCR-FGFR1-Driven 8p11 cell proliferation
title_full Proteomic analysis reveals dual requirement for Grb2 and PLCγ1 interactions for BCR-FGFR1-Driven 8p11 cell proliferation
title_fullStr Proteomic analysis reveals dual requirement for Grb2 and PLCγ1 interactions for BCR-FGFR1-Driven 8p11 cell proliferation
title_full_unstemmed Proteomic analysis reveals dual requirement for Grb2 and PLCγ1 interactions for BCR-FGFR1-Driven 8p11 cell proliferation
title_short Proteomic analysis reveals dual requirement for Grb2 and PLCγ1 interactions for BCR-FGFR1-Driven 8p11 cell proliferation
title_sort proteomic analysis reveals dual requirement for grb2 and plcγ1 interactions for bcr-fgfr1-driven 8p11 cell proliferation
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9093983/
https://www.ncbi.nlm.nih.gov/pubmed/35574218
http://dx.doi.org/10.18632/oncotarget.28228
work_keys_str_mv AT peirismalalagen proteomicanalysisrevealsdualrequirementforgrb2andplcg1interactionsforbcrfgfr1driven8p11cellproliferation
AT meyerapriln proteomicanalysisrevealsdualrequirementforgrb2andplcg1interactionsforbcrfgfr1driven8p11cellproliferation
AT wardadalida proteomicanalysisrevealsdualrequirementforgrb2andplcg1interactionsforbcrfgfr1driven8p11cellproliferation
AT camposalexandrerosa proteomicanalysisrevealsdualrequirementforgrb2andplcg1interactionsforbcrfgfr1driven8p11cellproliferation
AT donoghuedanielj proteomicanalysisrevealsdualrequirementforgrb2andplcg1interactionsforbcrfgfr1driven8p11cellproliferation